Not Much Energy or Leadership
The troops are making an effort to generate some upside action, and they even had a pretty good sentiment report to help out, but we just don't have much energy in front of the long weekend. Some folks are looking to bet on positive news out of Europe over the weekend, but many others are just as nervous about further negative developments.
Quite often, this sort of thin, choppy, pre-holiday trading will produce some pockets of action, but we aren't seeing much of that at all today. A few small-cap biotechs, such as Complete Genomics (GNOM), Rosetta Genomics (ROSG), Neptune Technologies and Bioresources (NEPT) and Repros Therapeutics (RPRX) are active, and a good earnings report from Frontline (FRO) has created slight interest in bulk shipping, but there really is no leadership or hot action to be found....106 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
